IRIS

1.1 Articolo in rivista: [26870] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.641 a 7.660 di 26.870
Titolo Data di pubblicazione Autore(i) File
Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study 1-gen-2013 Mangili, G; Sigismondi, C; Frigerio, L; Candiani, M; Savarese, A; Giorda, G; Lauria, R; Tamberi, S; Greggi, S; Lorusso, D
Risk factors for hospital readmission of elderly patients 1-gen-2013 Franchi, C.; Nobili, A.; Mari, D.; Tettamanti, M.; Djade, C. D.; Pasina, L.; Salerno, F.; Corrao, S.; Marengoni, A.; Iorio, A.; Marcucci, M.; Mannucci, P. M.; Selmi, C.; Investigators, Reposi
Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study 1-gen-2019 Tripodi, E; Cormio, G; De Giorgi, U; Valabrega, G; Rubino, D; Lepori, S; Maltese, G; Sabatucci, I; Lorusso, D
Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment, and pathology report 1-gen-2016 Signorelli, M; Bogani, G; Ditto, A; Martinelli, F; Chiappa, V; Lopez, C; Scaffa, C; Lorusso, D; Raspagliesi, F
A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials 1-gen-2013 Marcucci, M.; Sinclair, J. C.
Influenza vaccination and vitamin K antagonist treatment : a placebo-controlled, randomized, double-blind crossover study 1-gen-2010 Iorio, A.; Basileo, M.; Marcucci, M.; Guercini, F.; Camilloni, B.; Paccamiccio, E.; Vecchioli, M.; Iorio, A. M.
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors 1-gen-2021 Nero, C; Ciccarone, F; Pietragalla, A; Duranti, S; Daniele, G; Salutari, V; Carbone, Mv; Scambia, G; Lorusso, D
Risk of recurrence after a first unprovoked venous thromboembolism : external validation of the Vienna Prediction Model with pooled individual patient data 1-gen-2015 Marcucci, M.; Iorio, A.; Douketis, J. D.; Eichinger, S.; Tosetto, A.; Baglin, T.; Cushman, M.; Palareti, G.; Poli, D.; Tait, R. C.; Kyrle, P. A.
Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study 1-gen-2005 Adamo, V; Ferrandina, G; Spada, M; Ferrau, F; Condemi, G; Di Lullo, L; Lorusso, D; Rossello, R; Garipoli, C; Scambia, G
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 1-gen-2016 Marchetti, C; Ferrandina, G; Cormio, G; Gambino, A; Cecere, S; Lorusso, D; De Giorgi, U; Bogliolo, S; Fagotti, A; Mammoliti, S; Narducci, F; Bergamini, A; Scollo, P; Biglia, N; Breda, E; Tamberi, S; Marinaccio, M; Angioli, R; Salerno, L; Eusebi, Mc; Loizzi, V; Scambia, G; Panici, Pb
A tutorial on sensitivity analyses in clinical trials : the what, why, when and how 1-gen-2013 Thabane, L.; Mbuagbaw, L.; Zhang, S.; Samaan, Z.; Marcucci, M.; Ye, C.; Thabane, M.; Giangregorio, L.; Dennis, B.; Kosa, D.; Borg Debono, V.; Dillenburg, R.; Fruci, V.; Bawor, M.; Lee, J.; Wells, G.; Goldsmith, C. H.
MALIGNANT ASCITES IN CLINICAL PRACTICE: AIOM FOUNDATION SURVEY 1-gen-2009 Petrelli, Fausto; Lorusso, D; Bajetta, Emilio; Barni, Sandro
Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study 1-gen-2013 Pasina, L.; Djade, C. D.; Lucca, U.; Nobili, A.; Tettamanti, M.; Franchi, C.; Salerno, F.; Corrao, S.; Marengoni, A.; Iorio, A.; Marcucci, M.; Violi, F.; Mannucci, P. M.
Effectiveness of the interventions in preventing the progression of pre-frailty and frailty in older adults: a systematic review protocol 1-gen-2016 Apóstolo, J.; Cooke, R.; Bobrowicz Campos, E.; Santana, S.; Marcucci, M.; Cano, A.; Vollenbroek, M.; Holland, C.
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33) 1-gen-2021 Musacchio, L; Salutari, V; Pignata, S; Braicu, E; Cibula, D; Colombo, N; Frenel, Js; Zagouri, F; Carbone, V; Ghizzoni, V; Giolitto, S; Giudice, E; Perri, Mt; Ricci, C; Scambia, G; Lorusso, D
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial 1-gen-2020 Ray-Coquard, I; Harter, P; Lorusso, D; Dalban, C; Vergote, I; Fujiwara, K; Gladieff, L; Lück, H; Floquet, A; Chevalier-Place, A; Schnelzer, A; Pignata, S; Selle, F; Sehouli, J; Brocard, F; Mangili, G; Pautier, P; De Giorgi, U; Provansal, M; Heudel, P
Drug-drug interactions in a cohort of hospitalized elderly patients 1-gen-2013 Pasina, L.; Djade, C. D.; Nobili, A.; Tettamanti, M.; Franchi, C.; Salerno, F.; Corrao, S.; Marengoni, A.; Iorio, A.; Marcucci, M.; Mannucci, P.
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9) 1-gen-2010 Mangili, G.; Scarfone, G.; Gadducci, A.; Sigismondi, C.; Ferrandina, G.; Scibilia, G.; Vigano, R.; Tateo, S.; Villa, A.; Lorusso, D
Prospective validation of a predictive score for complete tumor resection in recurrent ovarian cancer (ROC): an intergroup study of AGO kommission OVAR, AGO-OVAR, AGO Austria, MITO and NOGGO 1-gen-2009 Sehouli, J.; Harter, P.; Reuss, A.; Hasenburg, A.; Scambia, G.; Cibula, D.; Mahner, S.; Vergote, I.; Reinthaller, A.; Burges, A.; Hanker, L.; Poelcher, M.; Kurzeder, C.; Canzler, U.; Petry, K. U.; Obermair, A.; Petru, E.; Schmalfeldt, B.; Lorusso, D; du Bois, A.
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix 1-gen-2014 Hasegawa, K; Nagao, S; Yasuda, M; Millan, D; Viswanathan, An; Glasspool, Rm; Devouassoux-Shisheboran, M; Covens, A; Lorusso, D; Kurzeder, C; Kim, Jw; Gladieff, L; Bryce, J; Friedlander, M; Fujiwara, K
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.641 a 7.660 di 26.870
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26870
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro723
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA456
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269074
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS227
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE182
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19414
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19151
  • ita408
  • spa13
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24617
  • reserved1362
  • open891